Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Canopus Develops New Image Distribution System for Hospitals
August 20, 2001
- BUSINESS NEWS IN BRIEF -1-
August 20, 2001
- MEDICAL DEVICE NEWS IN BRIEF
August 20, 2001
- BUSINESS NEWS IN BRIEF -2-
August 20, 2001
- Takara Launches 2 Additional DNA Chips
August 20, 2001
- Savings of \1.4 Trillion Possible by Reducing Drug Cost to 16%: Council Report
August 20, 2001
- Study on Diagnostic Method Using PALSAR Selected by JHSF
August 20, 2001
- 6th Designation for Quality Reevaluation Approved
August 20, 2001
- Development of Kissei's Rizaben Discontinued by GSK
August 6, 2001
- Sun Drug-Kawachi Yakuhin Alliance Likely to Be Successful: Security Analyst
August 6, 2001
- 3 Groups to Study How to Improve Supply of Drug Information
August 6, 2001
- BULLETIN
August 6, 2001
- BULLETIN
August 6, 2001
- Council Recommends Abolition of \205 Rule, Review of NHI Pricing Rule
August 6, 2001
- DIAGNOSTIC NEWS IN BRIEF
August 6, 2001
- Nippon Shinyaku to Focus on Unmet Market Needs: New President Hatsuyama
August 6, 2001
- 119 Voluntary Recalls of Drugs Reported in FY2000
August 6, 2001
- MEDICAL DEVICE NEWS IN BRIEF
August 6, 2001
- Nippon Chemiphar to Shift from Restructuring to Business Expansion: President Yamaguchi
August 6, 2001
- Mechanisms for Cancer Onset, Metastasis Expected to Be Clarified in 2014: Monkasho Survey
August 6, 2001
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…